NFE2L2 and STAT3 Converge on Common Targets to Promote Survival of Primary Lymphoma Cells

NFE2L2 and STAT3 are key pro-survival molecules, and thus, their targeting may represent a promising anti-cancer strategy. In this study, we found that a positive feedback loop occurred between them and provided evidence that their concomitant inhibition efficiently impaired the survival of PEL cell...

Full description

Bibliographic Details
Main Authors: Andrea Arena, Michele Di Crosta, Roberta Gonnella, Roberta Zarrella, Maria Anele Romeo, Rossella Benedetti, Maria Saveria Gilardini Montani, Roberta Santarelli, Gabriella D’Orazi, Mara Cirone
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/14/11598
_version_ 1797588985274433536
author Andrea Arena
Michele Di Crosta
Roberta Gonnella
Roberta Zarrella
Maria Anele Romeo
Rossella Benedetti
Maria Saveria Gilardini Montani
Roberta Santarelli
Gabriella D’Orazi
Mara Cirone
author_facet Andrea Arena
Michele Di Crosta
Roberta Gonnella
Roberta Zarrella
Maria Anele Romeo
Rossella Benedetti
Maria Saveria Gilardini Montani
Roberta Santarelli
Gabriella D’Orazi
Mara Cirone
author_sort Andrea Arena
collection DOAJ
description NFE2L2 and STAT3 are key pro-survival molecules, and thus, their targeting may represent a promising anti-cancer strategy. In this study, we found that a positive feedback loop occurred between them and provided evidence that their concomitant inhibition efficiently impaired the survival of PEL cells, a rare, aggressive B cell lymphoma associated with the gammaherpesvirus KSHV and often also EBV. At the molecular level, we found that NFE2L2 and STAT3 converged in the regulation of several pro-survival molecules and in the activation of processes essential for the adaption of lymphoma cells to stress. Among those, STAT3 and NFE2L2 promoted the activation of pathways such as MAPK3/1 and MTOR that positively regulate protein synthesis, sustained the antioxidant response, expression of molecules such as MYC, BIRC5, CCND1, and HSP, and allowed DDR execution. The findings of this study suggest that the concomitant inhibition of NFE2L2 and STAT3 may be considered a therapeutic option for the treatment of this lymphoma that poorly responds to chemotherapies.
first_indexed 2024-03-11T00:59:50Z
format Article
id doaj.art-8e717e52ac8e42f5b7f9f8a22c52b652
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T00:59:50Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-8e717e52ac8e42f5b7f9f8a22c52b6522023-11-18T19:42:05ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-07-0124141159810.3390/ijms241411598NFE2L2 and STAT3 Converge on Common Targets to Promote Survival of Primary Lymphoma CellsAndrea Arena0Michele Di Crosta1Roberta Gonnella2Roberta Zarrella3Maria Anele Romeo4Rossella Benedetti5Maria Saveria Gilardini Montani6Roberta Santarelli7Gabriella D’Orazi8Mara Cirone9Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, ItalyDepartment of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, ItalyDepartment of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, ItalyDepartment of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, ItalyDepartment of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, ItalyDepartment of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, ItalyDepartment of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, ItalyDepartment of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, ItalyDepartment of Neurosciences, Imaging and Clinical Sciences, University “G. D’Annunzio”, 66013 Chieti, ItalyDepartment of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, ItalyNFE2L2 and STAT3 are key pro-survival molecules, and thus, their targeting may represent a promising anti-cancer strategy. In this study, we found that a positive feedback loop occurred between them and provided evidence that their concomitant inhibition efficiently impaired the survival of PEL cells, a rare, aggressive B cell lymphoma associated with the gammaherpesvirus KSHV and often also EBV. At the molecular level, we found that NFE2L2 and STAT3 converged in the regulation of several pro-survival molecules and in the activation of processes essential for the adaption of lymphoma cells to stress. Among those, STAT3 and NFE2L2 promoted the activation of pathways such as MAPK3/1 and MTOR that positively regulate protein synthesis, sustained the antioxidant response, expression of molecules such as MYC, BIRC5, CCND1, and HSP, and allowed DDR execution. The findings of this study suggest that the concomitant inhibition of NFE2L2 and STAT3 may be considered a therapeutic option for the treatment of this lymphoma that poorly responds to chemotherapies.https://www.mdpi.com/1422-0067/24/14/11598PELSTAT3NRF2HSPsDDRp62/SQSTM1
spellingShingle Andrea Arena
Michele Di Crosta
Roberta Gonnella
Roberta Zarrella
Maria Anele Romeo
Rossella Benedetti
Maria Saveria Gilardini Montani
Roberta Santarelli
Gabriella D’Orazi
Mara Cirone
NFE2L2 and STAT3 Converge on Common Targets to Promote Survival of Primary Lymphoma Cells
International Journal of Molecular Sciences
PEL
STAT3
NRF2
HSPs
DDR
p62/SQSTM1
title NFE2L2 and STAT3 Converge on Common Targets to Promote Survival of Primary Lymphoma Cells
title_full NFE2L2 and STAT3 Converge on Common Targets to Promote Survival of Primary Lymphoma Cells
title_fullStr NFE2L2 and STAT3 Converge on Common Targets to Promote Survival of Primary Lymphoma Cells
title_full_unstemmed NFE2L2 and STAT3 Converge on Common Targets to Promote Survival of Primary Lymphoma Cells
title_short NFE2L2 and STAT3 Converge on Common Targets to Promote Survival of Primary Lymphoma Cells
title_sort nfe2l2 and stat3 converge on common targets to promote survival of primary lymphoma cells
topic PEL
STAT3
NRF2
HSPs
DDR
p62/SQSTM1
url https://www.mdpi.com/1422-0067/24/14/11598
work_keys_str_mv AT andreaarena nfe2l2andstat3convergeoncommontargetstopromotesurvivalofprimarylymphomacells
AT micheledicrosta nfe2l2andstat3convergeoncommontargetstopromotesurvivalofprimarylymphomacells
AT robertagonnella nfe2l2andstat3convergeoncommontargetstopromotesurvivalofprimarylymphomacells
AT robertazarrella nfe2l2andstat3convergeoncommontargetstopromotesurvivalofprimarylymphomacells
AT mariaaneleromeo nfe2l2andstat3convergeoncommontargetstopromotesurvivalofprimarylymphomacells
AT rossellabenedetti nfe2l2andstat3convergeoncommontargetstopromotesurvivalofprimarylymphomacells
AT mariasaveriagilardinimontani nfe2l2andstat3convergeoncommontargetstopromotesurvivalofprimarylymphomacells
AT robertasantarelli nfe2l2andstat3convergeoncommontargetstopromotesurvivalofprimarylymphomacells
AT gabrielladorazi nfe2l2andstat3convergeoncommontargetstopromotesurvivalofprimarylymphomacells
AT maracirone nfe2l2andstat3convergeoncommontargetstopromotesurvivalofprimarylymphomacells